Variation in Lipid-Lowering Therapy Use in Patients with LDL-C ≥ 190mg/dL: Insights from the NCDR(®)PINNACLE Registry

BACKGROUND: Patients with low-density lipoprotein cholesterol (LDL-C) ≥190mg/dL are at high-risk of atherosclerotic cardiovascular disease (ASCVD) events. Treatment guidelines recommend intensive treatment in these patients. Variation in the use of lipid-lowering therapies (LLT) in these patients in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Cardiovasc Qual Outcomes
Autors principals: Virani, Salim S., Kennedy, Kevin F., Akeroyd, Julia M., Morris, Pamela B., Bittner, Vera A., Masoudi, Frederick A., Stone, Neil J., Petersen, Laura A., Ballantyne, Christie M.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5951397/
https://ncbi.nlm.nih.gov/pubmed/29748356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.118.004652
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars